44 results
424B5
HUMA
Humacyte Inc
1 Mar 24
Prospectus supplement for primary offering
4:05pm
) on the gain derived from the sale, which gain may be offset by U.S.-source capital losses for the year; or
we are or have been a United States real property
424B5
HUMA
Humacyte Inc
29 Feb 24
Prospectus supplement for primary offering
4:11pm
an applicable income tax treaty) on the gain derived from the sale, which gain may be offset by U.S.-source capital losses for the year; or
we are or have
8-K
EX-99.1
nya x1yz7637ghssq5
9 Nov 23
Humacyte Third Quarter 2023 Financial Results and Business Update
4:07pm
8-K
EX-99.1
wi5iegr2v0 ge
10 Nov 22
Humacyte Third Quarter 2022 Financial Results and Business Update
7:04am
424B3
jvgc8j
12 Aug 22
Prospectus supplement
9:11am
8-K
EX-99.1
q0hi0sc 5sj9hugxt7j
12 Aug 22
Humacyte Second Quarter 2022 Financial Results and Business Update
7:04am
424B3
mt6kf6
13 May 22
Prospectus supplement
9:14am
8-K
EX-99.1
c7pnj2 yq14rdntuikb
13 May 22
Humacyte First Quarter 2022 Financial Results and Business Update
7:03am
DEF 14A
z2jsvi
29 Apr 22
Definitive proxy
6:41am
424B7
7nlqsnk5z
4 Apr 22
Prospectus with selling stockholder info
5:22pm